A widow is advocating for a legal amendment to eliminate disparities in care for individuals with brain cancer. Ellie James’ spouse, Owain, passed away in 2024 due to a glioblastoma, a type of brain tumor. His struggle to access personalized treatment stemmed from the lack of preservation of most of his tumor post-brain surgery.
Mrs. James is spearheading a movement to grant patients the right to have their tissue stored after surgery, facilitating access to tailored treatments and genetic examinations. Hailing from Caerphilly in south Wales, the 36-year-old highlighted the inconsistent implementation of this practice within the NHS, resulting in unequal care provision.
She is urging for a legislative alteration, named Owain’s Law, which would empower patients to provide consent regarding the handling of their tissue. Mrs. James expressed confidence that her husband would have survived if such a law had been in effect during his treatment.
The matter is set for deliberation in a Westminster Hall debate on Wednesday. Mr. James, a father of one, received a brain cancer diagnosis in September 2022. Following surgery, where medics removed half of his 14cm tumor, the family fundraised for personalized treatment. Mrs. James disclosed that the vaccine required fresh frozen tumor tissue, but due to improper preservation, only a small portion was viable for use, limiting the number of available vaccines.
Despite initial success with the treatment, subsequent tumor recurrence led to Mr. James’ demise in June 2024. Mrs. James lamented the missed opportunity for additional vaccines due to a decision made without adequate consent on the tissue’s handling. She stressed the importance of patient autonomy and informed consent in determining the fate of their tissue for future treatments or research.
Advocating for patients’ rights to choose, Owain’s Law aims to provide individuals with options and control over their tissue utilization.